Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 2 results for "Tecfidera"

Biogen wins Tecfidera U.S. patent dispute with Forward Pharma
Reuters

Biogen wins Tecfidera U.S. patent dispute with Forward Pharma

A U.S. patent board on Friday ruled against Danish drugmaker Forward Pharma A/S, finding Biogen's patents on its blockbuster multiple sclerosis drug Tecfidera to be valid. The ruling by the U.S. Patent Trial and Appeal Board (PTAP) frees Bigoen Inc from ... Reuters, 1 month ago

20 images for Tecfidera

Reuters, 1 month ago
Reuters, 2 months ago
pharmaphorum, 4 months ago
Nasdaq, 3 months ago
Ariva.de, 4 months ago
Nasdaq, 4 months ago
Medical Marketing And Media, 4 months ago
Yahoo! Finance, 4 months ago
Scrip Intelligence, 4 months ago
FiercePharma, 4 months ago
Reuters

Biogen wins ruling in Tecfidera IP case; shares rise

NEW YORK (Reuters) - Biogen Inc on Tuesday won an intellectual property rights ruling against hedge fund manager Kyle Bass over its top multiple sclerosis pill, Tecfidera, pushing shares up more than 1 percent on a day when most U.S. stocks were down.
 Reuters2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less